Developer docs
API playgroundTry for free, no card

Search company profiles

Pentabase

Full company profile

uuid000rfjl

Namestring
Pentabase
Legal namestring
PentaBase A/S
Websiteurl
pentabase.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

PentaBase is a Danish in vitro diagnostics company founded in 2006 and headquartered in Odense, Denmark. The company develops molecular diagnostic PCR assays and laboratory instruments for cancer detection and monitoring, built on its proprietary INA® (Intercalating Nucleic Acid) chemistry platform. INA®-based oligonucleotides incorporate covalently linked intercalating pseudo-nucleotides (IPNs) that increase π-stacking to deliver higher target affinity, specificity, and lower background fluorescence relative to standard DNA oligos, and the same chemistry underpins the company's probes, primers, and assays.

The portfolio is organized into three categories: (i) CE-IVD certified clinical assays for oncology and haematology, including SensiScreen FFPE and Liquid qPCR assays for somatic mutations (EGFR, BRAF, KRAS, NRAS, KIT, PIK3CA), EpiDirect MGMT and MLH1 methylation qPCR assays that bypass bisulfite conversion, MicroSight MSI for microsatellite instability via HRM, and PlentiPlex MYD88 and KIT for haematological malignancies; (ii) custom oligonucleotide reagents sold as research inputs (HydrolEasy probes, EasyBeacon probes, SuPrimers, EpiPrimers, BaseBlockers); and (iii) laboratory instruments with associated consumables, including BaseTyper real-time PCR systems (48.4 and 96.4/6), BasePurifier magnetic-bead extraction systems (32, 48, 96), and PANA 9600S and DC48 automated workstations. Most assays are validated as open-platform on third-party instruments from Bio-Rad, Applied Biosystems, Qiagen, Agilent, and IT-IS Life Science.

PentaBase commercializes through direct sales, an e-commerce storefront (shop.pentabase.com), and an authorized distributor network spanning more than 14 countries across Europe, Asia, the Middle East, and Oceania. Pricing is predominantly quote-based for assays and instruments, with unit-pricing published for certain oligonucleotides (e.g., BaseBlockers at €140-€500). In January 2026 the company obtained EU IVDR Class C certification (Certificate No. IVDR 790049 R000 from BSI Group, valid through January 2031) covering its IVD PCR assay portfolio. The company is privately held as PentaBase A/S (CVR 30 19 78 52) with no disclosed institutional investors or funding rounds, appearing to be founder/owner-operated with reported headcount of 1-10 employees.

Short descriptiontext

PentaBase is a Danish IVD company that develops CE-IVD/IVDR certified PCR assays for oncology and haematology diagnostics based on its proprietary INA® nucleic acid chemistry, serving clinical laboratories worldwide through direct sales, e-commerce, and a distributor network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOdense, Denmark
HQ citystring
Odense
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics, cancer detection assays, PCR diagnostics, in vitro diagnostics, clinical laboratory assays
Industry4 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
Molecular Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1IVD PCR Assays
TypeOne Time License
Description

Sale of CE-IVD certified PCR assays for oncology and haematology diagnostics including SensiScreen®, EpiDirect®, PlentiPlex™, and MicroSight® product families. These are the primary revenue drivers targeting clinical laboratories worldwide.

pentabase.com
2Instruments and Extraction Kits
TypeHardware Sales
Description

Sale of laboratory instruments including BasePurifier™ nucleic acid extraction systems and BaseTyper™ real-time PCR instruments, along with compatible extraction kits. Hardware sales with associated consumables.

pentabase.com
3Custom Oligonucleotides
TypeOne Time License
Description

Sale of customized INA®-based and standard oligonucleotides including probes, primers, and specialty oligos. Customers can order custom-designed products for specific PCR applications.

pentabase.com
4Assay Development Services
TypeProfessional Services
Description

Fast development service for custom tumor-informed dPCR and qPCR assays for MRD (Minimal Residual Disease) testing. Custom assays designed and produced on demand, shipped within 4 weeks.

pentabase.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Others
Pricing details1 tier
1Custom Oligonucleotides - BaseBlockers™
ModelUnit PricingBilling cadencePay-as-you-go
Notes

BaseBlockers™ reference pricing: €500 (design, 436), €140 (10 nmol, 437), €280 (50 nmol, 438)

pentabase.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 14 records shown
1SensiScreen®
Description

IVD PCR assays for somatic cancer mutations detection in FFPE and liquid biopsies

pentabase.com
+13 more records
Core offering1 text field

PentaBase develops and manufactures CE-IVD certified PCR-based in vitro diagnostic assays, instruments, and custom oligonucleotides for cancer detection and monitoring. Its proprietary INA® (Intercalating Nucleic Acid) chemistry underpins products for somatic mutation detection in FFPE and liquid biopsies, DNA methylation analysis, microsatellite instability testing, and haematology diagnostics, complemented by automated nucleic acid extraction systems and real-time PCR instruments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • EpiDirect® MGMT detects methylation levels as low as 1.5%
+4 more records
Product overview1 text field

Pentabase is a Danish in vitro diagnostics company offering a comprehensive molecular diagnostics portfolio centered on proprietary INA (Intercalating Nucleic Acid) technology. The product portfolio spans three main categories: (1) CE-IVD certified PCR assays including SensiScreen FFPE and Liquid qPCR assays for somatic cancer mutation detection, EpiDirect MGMT/MLH1 methylation assays for direct conversion-free DNA methylation analysis, MicroSight MSI for microsatellite instability evaluation, and PlentiPlex MYD88/KIT for haematology applications; (2) Custom oligonucleotides including HydrolEasy probes, EasyBeacon probes, SuPrimers, EpiPrimers, and BaseBlockers that form the technological backbone of all assays; (3) Instruments including BaseTyper real-time PCR systems (48.4 and 96.4/6), BasePurifier nucleic acid extraction systems (32, 48, 96), DC48 and PANA 9600S automated workstations, and BaseSNAP extraction kits. All products leverage INA technology for enhanced target affinity, specificity, and reduced background fluorescence. The instruments and assays are designed as open platforms compatible with standard real-time PCR instruments from major vendors.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Czech Republic and Croatia, Bosnia, Herzegovina, and Serbia markets. Provides local access to PentaBase's molecular diagnostics and PCR solutions.

2AnaChem Diagnostics
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Greece, providing local access to PentaBase's IVD assays and life science products.

pentabase.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Ukraine, providing local access to PentaBase's molecular diagnostics products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for France, providing local access to PentaBase's PCR solutions and molecular diagnostics.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Finland, providing local access to PentaBase's IVD assays and instruments.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Romania, providing local access to PentaBase's molecular diagnostics products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Slovakia, providing local access to PentaBase's PCR solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Turkey, providing local access to PentaBase's molecular diagnostics.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Germany and Austria, providing local access to PentaBase's IVD assays and instruments.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Italy, providing local access to PentaBase's PCR solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Bulgaria, providing local access to PentaBase's molecular diagnostics products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Kazakhstan, providing local access to PentaBase's IVD assays.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Qatar, providing local access to PentaBase's molecular diagnostics.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for New Zealand, providing local access to PentaBase's PCR solutions and instruments.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global molecular diagnostics leader offering real-time PCR kits, sample-preparation instruments, and oncology assays. Direct competitor in PCR-based mutation detection and methylation testing; PentaBase validates on Qiagen's Rotor-Gene Q, underscoring product overlap.

TypeDirect peer
Description

Singapore-headquartered molecular diagnostics company providing PCR and NGS oncology and infectious disease kits with IVD regulatory clearances. Comparable in offering CE-IVD oncology PCR assays to clinical labs globally.

TypeBroad incumbent
Description

Diversified life-sciences giant with the QuantStudio and ABI 7500 real-time PCR instruments, plus oncology molecular diagnostic content. PentaBase assays are validated on QuantStudio 5 and ABI 7500, reflecting direct platform competition.

TypeDirect peer
Description

Italian molecular diagnostics company specializing in CE-IVD real-time PCR kits for oncology and pharmacogenetics. Comparable in CE-IVD oncology assay portfolio, European market focus, and clinical-lab customer base.

TypeEmerging player
Description

Specialist in digital PCR (naica® system) for oncology liquid biopsy and rare-mutation detection. Comparable to PentaBase's BaseBlockers-enabled low-frequency SNV detection in liquid biopsy workflows.

TypeDirect peer
Description

China-based oncology molecular diagnostics company offering real-time PCR and NGS-based companion diagnostic kits for EGFR, KRAS, BRAF, and other targets. Directly comparable menu and clinical-lab customer base to PentaBase's SensiScreen line.

TypeDirect peer
Description

Manufacturer of real-time PCR instruments (CFX96, CFX Opus) and an extensive portfolio of PCR reagents and ddPCR systems. Directly comparable in oncology qPCR reagents and instrument platforms that PentaBase's assays are validated to run on.

TypeDirect peer
Description

Belgium-based molecular diagnostics company commercializing the Idylla™ fully automated PCR platform with oncology mutation panels. Directly comparable in offering CE-IVD oncology PCR assays to clinical laboratories in Europe.

TypeDirect peer
Description

Developer of real-time PCR-based oncology and hematology diagnostic kits for clinical laboratories. Comparable menu (KRAS, BRAF, EGFR, JAK2, BCR-ABL) and CE-IVD regulatory positioning to PentaBase.

10IT-IS Life Science (MyGo)
TypeEmerging player
Description

Manufacturer of the compact MyGo Pro real-time PCR instrument, which PentaBase validates extensively across SensiScreen assays. Closely intertwined through instrument/assay co-validation, making MyGo both a partner and a potential instrument-competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration29 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pentabase

Molecular Diagnosticspentabase.com

PentaBase is a Danish IVD company that develops CE-IVD/IVDR certified PCR assays for oncology and haematology diagnostics based on its proprietary INA® nucleic acid chemistry, serving clinical laboratories worldwide through direct sales, e-commerce, and a distributor network.

What Pentabase does

PentaBase is a Danish in vitro diagnostics company founded in 2006 and headquartered in Odense, Denmark. The company develops molecular diagnostic PCR assays and laboratory instruments for cancer detection and monitoring, built on its proprietary INA® (Intercalating Nucleic Acid) chemistry platform. INA®-based oligonucleotides incorporate covalently linked intercalating pseudo-nucleotides (IPNs) that increase π-stacking to deliver higher target affinity, specificity, and lower background fluorescence relative to standard DNA oligos, and the same chemistry underpins the company's probes, primers, and assays.

The portfolio is organized into three categories: (i) CE-IVD certified clinical assays for oncology and haematology, including SensiScreen FFPE and Liquid qPCR assays for somatic mutations (EGFR, BRAF, KRAS, NRAS, KIT, PIK3CA), EpiDirect MGMT and MLH1 methylation qPCR assays that bypass bisulfite conversion, MicroSight MSI for microsatellite instability via HRM, and PlentiPlex MYD88 and KIT for haematological malignancies; (ii) custom oligonucleotide reagents sold as research inputs (HydrolEasy probes, EasyBeacon probes, SuPrimers, EpiPrimers, BaseBlockers); and (iii) laboratory instruments with associated consumables, including BaseTyper real-time PCR systems (48.4 and 96.4/6), BasePurifier magnetic-bead extraction systems (32, 48, 96), and PANA 9600S and DC48 automated workstations. Most assays are validated as open-platform on third-party instruments from Bio-Rad, Applied Biosystems, Qiagen, Agilent, and IT-IS Life Science.

PentaBase commercializes through direct sales, an e-commerce storefront (shop.pentabase.com), and an authorized distributor network spanning more than 14 countries across Europe, Asia, the Middle East, and Oceania. Pricing is predominantly quote-based for assays and instruments, with unit-pricing published for certain oligonucleotides (e.g., BaseBlockers at €140-€500). In January 2026 the company obtained EU IVDR Class C certification (Certificate No. IVDR 790049 R000 from BSI Group, valid through January 2031) covering its IVD PCR assay portfolio. The company is privately held as PentaBase A/S (CVR 30 19 78 52) with no disclosed institutional investors or funding rounds, appearing to be founder/owner-operated with reported headcount of 1-10 employees.

Pentabase firmographics

Firmographics
Name
Pentabase
Legal name
PentaBase A/S
Website
https://pentabase.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
PentaBase is a Danish IVD company that develops CE-IVD/IVDR certified PCR assays for oncology and haematology diagnostics based on its proprietary INA® nucleic acid chemistry, serving clinical laboratories worldwide through direct sales, e-commerce, and a distributor network.
Ownership category
akta.pro rank

Pentabase industry classification

Industry
Product category
Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Keywords

  • Molecular diagnostics
  • Cancer detection assays
  • PCR diagnostics
  • In vitro diagnostics
  • Clinical laboratory assays

Where Pentabase is headquartered

Location

Headquarters

HQ city
Odense
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

Pentabase business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Others

Revenue model

  1. IVD PCR Assays: Sale of CE-IVD certified PCR assays for oncology and haematology diagnostics including SensiScreen®, EpiDirect®, PlentiPlex™, and MicroSight® product families. These are the primary revenue drivers targeting clinical laboratories worldwide.
  2. Instruments and Extraction Kits: Sale of laboratory instruments including BasePurifier™ nucleic acid extraction systems and BaseTyper™ real-time PCR instruments, along with compatible extraction kits. Hardware sales with associated consumables.
  3. Custom Oligonucleotides: Sale of customized INA®-based and standard oligonucleotides including probes, primers, and specialty oligos. Customers can order custom-designed products for specific PCR applications.
  4. Assay Development Services: Fast development service for custom tumor-informed dPCR and qPCR assays for MRD (Minimal Residual Disease) testing. Custom assays designed and produced on demand, shipped within 4 weeks.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCustom Oligonucleotides - BaseBlockers™

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Pentabase product offering

Product offering

Core offering

PentaBase develops and manufactures CE-IVD certified PCR-based in vitro diagnostic assays, instruments, and custom oligonucleotides for cancer detection and monitoring. Its proprietary INA® (Intercalating Nucleic Acid) chemistry underpins products for somatic mutation detection in FFPE and liquid biopsies, DNA methylation analysis, microsatellite instability testing, and haematology diagnostics, complemented by automated nucleic acid extraction systems and real-time PCR instruments.

Product overview

Pentabase is a Danish in vitro diagnostics company offering a comprehensive molecular diagnostics portfolio centered on proprietary INA (Intercalating Nucleic Acid) technology. The product portfolio spans three main categories: (1) CE-IVD certified PCR assays including SensiScreen FFPE and Liquid qPCR assays for somatic cancer mutation detection, EpiDirect MGMT/MLH1 methylation assays for direct conversion-free DNA methylation analysis, MicroSight MSI for microsatellite instability evaluation, and PlentiPlex MYD88/KIT for haematology applications; (2) Custom oligonucleotides including HydrolEasy probes, EasyBeacon probes, SuPrimers, EpiPrimers, and BaseBlockers that form the technological backbone of all assays; (3) Instruments including BaseTyper real-time PCR systems (48.4 and 96.4/6), BasePurifier nucleic acid extraction systems (32, 48, 96), DC48 and PANA 9600S automated workstations, and BaseSNAP extraction kits. All products leverage INA technology for enhanced target affinity, specificity, and reduced background fluorescence. The instruments and assays are designed as open platforms compatible with standard real-time PCR instruments from major vendors.

Differentiator

Problem solved

Functional benefit

Brands

  • SensiScreen®: IVD PCR assays for somatic cancer mutations detection in FFPE and liquid biopsies
  • EpiDirect®
  • PlentiPlex™
  • MicroSight® MSI
  • BaseTyper™
  • BasePurifier™
  • BaseSNAP™
  • BaseBlockers™
  • HydrolEasy®
  • EasyBeacon™
  • SuPrimers™
  • EpiPrimers™
  • PANA 9600S
  • DC48

Quantifiable outcome

  • EpiDirect® MGMT detects methylation levels as low as 1.5%
  • +4 more outcomes

Companies that use Pentabase

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Pentabase technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration29 records

AI capability6 records

Feature8 records

Pentabase partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core.

  • Altium Česká republika / Altium InternationalcoreChannel Partner/ Reseller/ DistributorDistributor for Czech Republic and Croatia, Bosnia, Herzegovina, and Serbia markets. Provides local access to PentaBase's molecular diagnostics and PCR solutions.
  • AnaChem DiagnosticscoreChannel Partner/ Reseller/ DistributorDistributor for Greece, providing local access to PentaBase's IVD assays and life science products.
  • BIONIX LABcoreChannel Partner/ Reseller/ DistributorDistributor for Ukraine, providing local access to PentaBase's molecular diagnostics products.
  • Calibre ScientificcoreChannel Partner/ Reseller/ DistributorDistributor for France, providing local access to PentaBase's PCR solutions and molecular diagnostics.
  • LabemacoreChannel Partner/ Reseller/ DistributorDistributor for Finland, providing local access to PentaBase's IVD assays and instruments.
  • DextercoreChannel Partner/ Reseller/ DistributorDistributor for Romania, providing local access to PentaBase's molecular diagnostics products.
  • DYNEXcoreChannel Partner/ Reseller/ DistributorDistributor for Slovakia, providing local access to PentaBase's PCR solutions.
  • Genom Saglik UrunlericoreChannel Partner/ Reseller/ DistributorDistributor for Turkey, providing local access to PentaBase's molecular diagnostics.
  • HiSS DiagnosticscoreChannel Partner/ Reseller/ DistributorDistributor for Germany and Austria, providing local access to PentaBase's IVD assays and instruments.
  • ResnovacoreChannel Partner/ Reseller/ DistributorDistributor for Italy, providing local access to PentaBase's PCR solutions.
  • RidacomcoreChannel Partner/ Reseller/ DistributorDistributor for Bulgaria, providing local access to PentaBase's molecular diagnostics products.
  • Micro SolutionscoreChannel Partner/ Reseller/ DistributorDistributor for Kazakhstan, providing local access to PentaBase's IVD assays.
  • SEDEERcoreChannel Partner/ Reseller/ DistributorDistributor for Qatar, providing local access to PentaBase's molecular diagnostics.
  • Ngaio DiagnosticscoreChannel Partner/ Reseller/ DistributorDistributor for New Zealand, providing local access to PentaBase's PCR solutions and instruments.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Pentabase competitors and assessment

Company assessment

Direct peers

  • Qiagen: Global molecular diagnostics leader offering real-time PCR kits, sample-preparation instruments, and oncology assays. Direct competitor in PCR-based mutation detection and methylation testing; PentaBase validates on Qiagen's Rotor-Gene Q, underscoring product overlap.
  • Vela Diagnostics: Singapore-headquartered molecular diagnostics company providing PCR and NGS oncology and infectious disease kits with IVD regulatory clearances. Comparable in offering CE-IVD oncology PCR assays to clinical labs globally.
  • Diatech Pharmacogenetics: Italian molecular diagnostics company specializing in CE-IVD real-time PCR kits for oncology and pharmacogenetics. Comparable in CE-IVD oncology assay portfolio, European market focus, and clinical-lab customer base.
  • Amoy Diagnostics: China-based oncology molecular diagnostics company offering real-time PCR and NGS-based companion diagnostic kits for EGFR, KRAS, BRAF, and other targets. Directly comparable menu and clinical-lab customer base to PentaBase's SensiScreen line.
  • Bio-Rad Laboratories: Manufacturer of real-time PCR instruments (CFX96, CFX Opus) and an extensive portfolio of PCR reagents and ddPCR systems. Directly comparable in oncology qPCR reagents and instrument platforms that PentaBase's assays are validated to run on.
  • Biocartis: Belgium-based molecular diagnostics company commercializing the Idylla™ fully automated PCR platform with oncology mutation panels. Directly comparable in offering CE-IVD oncology PCR assays to clinical laboratories in Europe.
  • EntroGen: Developer of real-time PCR-based oncology and hematology diagnostic kits for clinical laboratories. Comparable menu (KRAS, BRAF, EGFR, JAK2, BCR-ABL) and CE-IVD regulatory positioning to PentaBase.

Broad incumbents

  • Thermo Fisher Scientific (Applied Biosystems): Diversified life-sciences giant with the QuantStudio and ABI 7500 real-time PCR instruments, plus oncology molecular diagnostic content. PentaBase assays are validated on QuantStudio 5 and ABI 7500, reflecting direct platform competition.

Emerging players

  • Stilla Technologies: Specialist in digital PCR (naica® system) for oncology liquid biopsy and rare-mutation detection. Comparable to PentaBase's BaseBlockers-enabled low-frequency SNV detection in liquid biopsy workflows.
  • IT-IS Life Science (MyGo): Manufacturer of the compact MyGo Pro real-time PCR instrument, which PentaBase validates extensively across SensiScreen assays. Closely intertwined through instrument/assay co-validation, making MyGo both a partner and a potential instrument-competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Pentabase social profiles

Digital presence

Pentabase compliance and trust

Trust signal

Compliance3 records

Pentabase financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pentabase leadership team

Management profile

Number of profiles

Pentabase funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pentabase M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pentabase

What does Pentabase do?

PentaBase develops and manufactures CE-IVD certified PCR-based in vitro diagnostic assays, instruments, and custom oligonucleotides for cancer detection and monitoring. Its proprietary INA® (Intercalating Nucleic Acid) chemistry underpins products for somatic mutation detection in FFPE and liquid biopsies, DNA methylation analysis, microsatellite instability testing, and haematology diagnostics, complemented by automated nucleic acid extraction systems and real-time PCR instruments.

Is Pentabase a public or private company?

Pentabase is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Pentabase founded?

Pentabase was founded in 2006. It employs 11 to 50 people.

Where is Pentabase based?

Pentabase is headquartered in Odense, Denmark, in the Europe region.

How does Pentabase make money?

Four revenue lines are on record. IVD PCR Assays are the primary driver. The others are instruments and Extraction Kits, custom Oligonucleotides and assay Development Services.

Who are Pentabase's main competitors?

Direct peers on record are Qiagen, Vela Diagnostics, Diatech Pharmacogenetics, Amoy Diagnostics, Bio-Rad Laboratories, Biocartis and EntroGen. Thermo Fisher Scientific (Applied Biosystems) is listed as a broad incumbent. Emerging players are Stilla Technologies and IT-IS Life Science (MyGo).

Does Pentabase have an API?

No public API is recorded for Pentabase.

What industry is Pentabase in?

Pentabase's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals